On March 2, 2021, Austerlitz Acquisition Corporation I (the “Company”) consummated its initial public offering (“IPO”) of 69,000,000 units (the “Units”), including the issuance of 9,000,000 Units as a result of the underwriter’s exercise in full of its over-allotment option. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), and one-fourth of one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Ordinary Share at an exercise price of $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $690,000,000.
Substantially concurrently with the consummation of the IPO, the Company completed the private sale (the “Private Placement”) of 10,533,333 warrants (the “Private Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant, to Austerlitz Acquisition Sponsor, LP I, generating gross proceeds to the Company of approximately $15,800,000.
A total of $690,000,000, comprised of $676,200,000 of the proceeds from the sale of the Units in the IPO, including approximately $24,150,000 of the underwriters’ deferred discount, and $13,800,000 of the proceeds of the sale of the Private Placement Warrants, were placed in a trust account, maintained by Continental Stock Transfer & Trust Company, acting as trustee.
An audited balance sheet as of March 2, 2021, reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement, is included as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits. The following exhibits are filed with this Form 8-K:
2